Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tunitas Therapeutics Inc.

Latest From Tunitas Therapeutics Inc.

Execs On The Move, May 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Venture Funding Deals, November 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.

BioPharmaceutical Medical Device

DBV Technologies Plans Strategy For Peanut Allergy Debut In U.S.

The French biotech will set out its stall first in the U.S., where peanut allergy is a major concern, and plans to tackle the life-threatening condition with its transdermal patch without relying on local partners.

BioPharmaceutical United States

Start-Up Previews, March 2013

This Month's Profile Group: Nanomedicine: Will It Get Big?, features profiles of Blend Therapeutics, Kala Pharmaceuticals, Qualiber, and Uroboros Technologies. Plus these Start-Ups Across Health Care: Ceterix Orthopaedics, Flux Medical, Neuros Medical, and Tunitas Therapeutics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Immune Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Tunitas Therapeutics Inc.
  • Senior Management
  • Nolan H Sigal, MD, PhD, Pres. & CEO
    Andrew Saxon, MD, CSO
  • Contact Info
  • Tunitas Therapeutics Inc.
    Phone: (650) 887-4747
    409 Illinois St.
    San Francisco, CA 94158